CRT also operates as a CRO in many circumstances. We provide the following services to pharmaceutical and biotech companies:

(1) Conduct and oversight of studies in Phases I-IV, from site selection to site oversight;
(2) Feasibility procedures;
(3) Consulting on each Phase of a clinical trial, ranging from guidance on protocol creation to the conduct of the Phases themselves;
(4) Protocol writing and IRB approval;
(5) Conducting the study process for Phase 0-I of biosimilar drugs from concept to completion; and
(6) Many other facets of the clinical trial process.

The above list is not an exhaustive list. CRT personnel have been involved in every stage of the clinical research process and have performed at the highest and most scrutinized levels. CRT has site experience, network experience, and concept-to-completion experience.